If you've ever found yourself feeling increasingly drawn to a stock that's constantly rising in price, you are not alone... Since the dawn of the stock market, speculators have been captured by the tendency of prices to 'trend'. When...
4142 — Adimmune Share Price
0.000.00%
Last Trade - 00:00HealthcareSpeculativeMid Capn/a
- TWD20.77bn
- TWD18.51bn
- TWD1.51bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 606.73 | 562.74 | 822.37 | 1,299.69 | 1,869.15 | 2,250 | n/a | 45.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for 4142
If you've ever found yourself feeling increasingly drawn to a stock that's constantly rising in price, you are not alone... Since the dawn of the stock market, speculators have been captured by the tendency of prices to 'trend'. When...
Studies by leading experts into the power of price momentum show that stocks with the strongest price trends tend to keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology. With...
With shares in Adimmune (TPE:4142) currently trading close to a 52 week high, a question many on the sidelines probably have is: "was I too late to buy them"? The share price is up by around 16.9% over the past week. On a one-month bas...
Profile Summary
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
Directors
- Chi-Shean Chan CHM
- Chin-Chuan Chang COO
- Peter Pan
- Chung-Cheng Liu GMG
- Jin-Yi Chiou
- Simon Kao DGM
- Yinteng Zhang
- Jeff Chen
- Weiguang Ji DRC
- Jiheng Lin
- Jingzhe Lin
- Rongjin Lin
- Meixing Zeng
- Meixiang He
- Paul Hsu
- Yun-Sheng Hsu
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- December 22nd, 1965
- Public Since
- September 29th, 2010
- No. of Employees
- 515
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 429,508,000
- Address
- No.3, TAICHUNG, 427
- Web
- http://www.adimmune.com.tw
- Phone
- +886 425381220
- Contact
- Peter Pan
- Auditors
- PricewaterhouseCoopers LLP
Upcoming events for 4142
Similar to 4142
CHUNGHWA CHEM ORD
Taiwan Stock Exchange
PHYTOHEALTH ORD
Taiwan Stock Exchange
FAQ
What is the Adimmune share price?
As of Today at 19:56 UTC, shares in Adimmune are trading at TWD48.35. This share price information is delayed by 15 minutes.
How has the Adimmune share price performed this year?
Shares in Adimmune last closed at TWD48.35 and the price had moved by -24.69% over the past 365 days. In terms of relative price strength the Adimmune share price has underperformed the FTSE Developed Asia Pacific Index by -40.65% over the past year.
What are the analyst and broker recommendations for Adimmune?
The overall consensus recommendation for Adimmune is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Adimmune dividend yield?
The Adimmune dividend yield is 1.03% based on the trailing twelve month period.
Does Adimmune pay a dividend?
Last year, Adimmune paid a total dividend of TWD0.50, and it currently has a trailing dividend yield of 1.03%. We do not have any data on when Adimmune is to next pay dividends.
When does Adimmune next pay dividends?
We do not have data on when Adimmune is to next pay dividends. The historic dividend yield on Adimmune shares is currently 1.03%.
How do I buy Adimmune shares?
To buy shares in Adimmune you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Adimmune?
As of the previous close price of TWD48.35, shares in Adimmune had a market capitalisation of TWD20.77bn.
Where are Adimmune shares listed?
Here are the trading details for Adimmune:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4142
What kind of share is Adimmune?
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Adimmune does not currently have a style classification.
Is there a Adimmune share price forecast for 2021?
The analyst consensus target price for shares in Adimmune is TWD92.00. That is 90.28% above the last closing price of TWD48.35.
Analysts covering Adimmune currently have a consensus Earnings Per Share (EPS) forecast of -TWD3.68 for the next financial year.
What is the trend in the Adimmune share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adimmune. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -10.06%.
As of the last closing price of TWD48.35, shares in Adimmune were trading -12.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Adimmune PE Ratio?
We are not able to find PE ratio data for Adimmune.
Who are the key directors of Adimmune?
Adimmune's management team is headed by:
- Chi-Shean Chan - CHM
- Chin-Chuan Chang - COO
- Peter Pan -
- Chung-Cheng Liu - GMG
- Jin-Yi Chiou -
- Simon Kao - DGM
- Yinteng Zhang -
- Jeff Chen -
- Weiguang Ji - DRC
- Jiheng Lin -
- Jingzhe Lin -
- Rongjin Lin -
- Meixing Zeng -
- Meixiang He -
- Paul Hsu -
- Yun-Sheng Hsu -
Who are the major shareholders of Adimmune?
We do not have data on Adimmune's shareholders